Log in
Enquire now
‌

US Patent 10906879 Crystalline substituted pyrazines as PGI2 receptor agonists

Patent 10906879 was granted and assigned to Nippon Shinyaku on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Nippon Shinyaku
Nippon Shinyaku
0
Current Assignee
Nippon Shinyaku
Nippon Shinyaku
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109068790
Patent Inventor Names
Toshio Fujiwara0
Date of Patent
February 2, 2021
0
Patent Application Number
166503900
Date Filed
September 27, 2018
0
Patent Primary Examiner
‌
Brian E McDowell
0
Patent abstract

A main object of the present invention is to provide a novel crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid (hereinafter referred to as “Compound B”).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10906879 Crystalline substituted pyrazines as PGI2 receptor agonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.